Tailoring Varenicline to Individual Needs (TVIN Study)

NCT01206010 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Tobacco Dependence
Smoking Cessation

Interventions

DRUG: Varenicline
DRUG: Placebo
DRUG: Varenicline

Sponsor

Queen Mary University of London